Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
DXC reports after market close, meaning Day 0 captures any anticipatory trading before results drop, while Day +1 reflects the market's first full session to digest the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | +$0.54 (+4.71%) | $0.47 (4.14%) | -$2.58 (-21.48%) | $1.88 (15.64%) |
| 2026-01-29 | -$0.02 (-0.14%) | $0.51 (3.53%) | +$0.02 (+0.14%) | $1.86 (12.91%) |
| 2025-10-30 | -$0.23 (-1.75%) | $0.34 (2.58%) | +$1.26 (+9.74%) | $1.02 (7.88%) |
| 2025-07-31 | -$0.12 (-0.87%) | $0.35 (2.55%) | -$0.75 (-5.51%) | $1.38 (10.14%) |
| 2025-05-14 | -$0.38 (-2.24%) | $0.90 (5.31%) | -$0.54 (-3.26%) | $2.23 (13.44%) |
| 2025-02-04 | +$0.60 (+2.73%) | $1.39 (6.32%) | -$0.50 (-2.21%) | $1.74 (7.70%) |
| 2024-11-07 | +$1.15 (+5.37%) | $1.35 (6.30%) | -$0.92 (-4.07%) | $3.30 (14.61%) |
| 2024-08-08 | +$0.40 (+2.23%) | $0.52 (2.90%) | +$1.31 (+7.15%) | $1.73 (9.44%) |
| Avg Abs Move | 2.50% | 4.20% | 6.70% | 11.47% |
Historical price action around DXC earnings has been volatile and directionally inconsistent, with Day +1 moves averaging 6.70% in absolute terms—well below the 11.47% average intraday range, indicating sharp swings that often reverse intraday. The most recent report (May 2026) saw a 4.71% Day 0 gain followed by a brutal -21.48% Day +1 plunge, the largest single-session drop in the dataset. Prior quarters showed more muted Day 0 reactions (often under 2%) but meaningful Day +1 follow-through, both positive (+9.74% in October 2025) and negative (-5.51% in July 2025).
The takeaway: DXC tends to move modestly on earnings day itself, then experience a larger directional move the following session as investors digest guidance and management commentary. The 2.50% average Day 0 move suggests limited pre-announcement positioning, while the 6.70% Day +1 average reflects genuine fundamental reassessment. However, the wide variance (ranging from -21.48% to +9.74%) means predicting direction is a coin flip—what's certain is that volatility spikes post-earnings, and recent history skews negative when results or guidance disappoint even modestly.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 23) |
| Expected Move | $1.85 (15.73%) |
| Expected Range | $9.93 to $13.63 |
| Implied Volatility | 84.38% |
The options market is pricing a 15.73% expected move by the August 21 expiration (23 days out), implying a range of $9.93 to $13.63. This is significantly higher than the historical 6.70% average Day +1 move and even exceeds the 11.47% average Day +1 range, suggesting options traders are bracing for an outsized reaction—possibly reflecting heightened uncertainty around guidance or a potential strategic announcement. The elevated implied volatility (84.38% average) indicates the market is pricing in substantial event risk beyond typical earnings volatility.
Analyst sentiment on DXC is decidedly cautious, with the consensus rating at 2.60—squarely in Sell-to-Hold territory. The breakdown shows 8 Hold ratings and 2 Strong Sells among 10 analysts, with zero Buy or Strong Buy recommendations. The average price target of $11.33 sits just 3.7% below the current price of $11.77, implying analysts see limited downside but virtually no upside from current levels. The range of targets is narrow ($9.00 to $16.00), with the high-end outlier at $16 representing a 36% premium that appears increasingly disconnected from consensus reality.
Sentiment has improved modestly over the past month, according to the precomputed trend indicator, though this likely reflects a technical rebound from oversold levels rather than fundamental optimism. A month ago, the average recommendation was 2.40 (more bearish), and the analyst count included 3 Strong Sells versus 2 today—so the shift is marginal at best. The lack of any Buy-rated coverage is telling: even bulls have capitulated or moved to the sidelines.
The $11.33 mean target implies -3.7% downside from the current $11.77 price, a rare setup where the stock is trading above consensus fair value heading into earnings. This suggests analysts believe the recent rally (DXC is up from the low-$9 range in recent months) has overshot fundamentals, and that tomorrow's report is unlikely to justify further gains without a material positive surprise on revenue or guidance. For investors, the message is clear: the Street sees DXC as a "show me" story where management must deliver tangible proof of stabilization before analysts will upgrade estimates or price targets.
The Barchart Technical Opinion has deteriorated sharply in recent weeks, signaling growing technical fragility heading into earnings. The current signal stands at 8% Sell, a dramatic improvement from 40% Sell last week and 100% Sell a month ago—but this reversal reflects a short-term bounce rather than a sustainable trend shift, as the underlying timeframe analysis reveals persistent weakness.
Timeframe Analysis:
Trend Characteristics: The overall setup is characterized by Weak strength and a Weakening direction, indicating the recent bounce lacks conviction and the path of least resistance remains lower absent a strong catalyst.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $10.46 | 50-Day MA | $9.34 |
| 10-Day MA | $9.92 | 100-Day MA | $10.55 |
| 20-Day MA | $9.76 | 200-Day MA | $12.21 |
From a moving average perspective, DXC is trading above its 5-day ($10.46), 10-day ($9.92), 20-day ($9.76), 50-day ($9.34), and 100-day ($10.55) averages, but critically remains below the 200-day moving average at $12.21—a key long-term resistance level that has capped rallies throughout 2026. The current price of $11.77 sits in a technical no-man's land: above short-term support but unable to reclaim the 200-day, which would signal a genuine trend reversal. The 15.73% options-implied move suggests the market is pricing in a potential test of either the $9.93 support zone (near the 50-day MA) or a breakout attempt toward $13.63 (above the 200-day). Overall, the technical setup is cautiously bearish—the stock has bounced off oversold levels, but lacks the momentum or breadth to inspire confidence heading into a high-stakes earnings event. A miss or weak guidance could quickly erase recent gains and send DXC back toward the $9–$10 support cluster.